Position in DXCM
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$34,791
-$22,154 QoQ
Shares Held
554
-35.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026ANTIPODES PARTNERS Ltd holds $78,714,253 across 9 Medical Devices names. DXCM ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMED |
Globus Medical Inc
|
897,607 | $77,337,819 | |
| 2 | BRKR |
Bruker Corp
|
23,313 | $842,065 | |
| 3 | STE |
STERIS plc
|
612 | $135,331 | |
| 4 | SYK |
Stryker Corp
|
362 | $118,949 | |
| 5 | IRTC |
iRhythm Holdings, Inc.
|
655 | $77,303 | |
| 6 | BSX |
Boston Scientific Corp
|
1,128 | $70,782 | |
| 7 | SIBN |
SI-BONE, Inc.
|
5,564 | $70,273 | |
| 8 | DXCM |
Dexcom Inc
This page
|
554 | $34,791 |
All Filings in DXCM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,791 | 554 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $56,945 | 858 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $108,807 | 1,617 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $73,672 | 844 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $133,984 | 1,962 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||